CARIS gained FDA approval for its MI Cancer Seek test and was subsequently listed on the Nasdaq stock exchange.

The entities involved

• CARIS →

  software company in Canada

  • CARIS filed a transaction with the SEC and its stock is listed on Nasdaq.Fri 10:15
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Nasdaq →

  American fully electronic stock exchange

  • Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
  • Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

• Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.Sep 2
• Takeda announced FDA approval of its drug MIMRYLO, a decision supported by VERIFY results.Aug 29
• Decoy Therapeutics is listed on the Nasdaq stock exchange and is currently seeking expedited regulatory approval via FDA pathways.Sep 22
• Capricor Therapeutics is seeking regulatory approval from the FDA for clinical trials and has listed on the Nasdaq stock exchange, with a law firm based in New York City involved.Aug 5
• uniQure N.V. traded on the Nasdaq stock exchange and submitted a Biologics License Application (BLA) for accelerated approval of its gene therapy.Sep 9